AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Airasit 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Airas Healthcare Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Airasit 50/500 Tablet

Diabetease 50/500 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Diabetease 50/500 may be used independently or in conjunction with other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and existing medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Maintaining your prescribed diet and exercise regimen is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially with concurrent use of insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all individuals. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before use. Pregnant or lactating women must consult their doctor. Interactions with other medications are possible; disclose all your medications to ensure safety. Alcohol should be minimized due to its potential to lower blood sugar. Your doctor will monitor kidney function and glucose levels throughout treatment.

Uses of Airasit 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Airasit 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Airasit 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Airasit 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Airasit 50/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Airasit 50/500 Tablets should be administered with a meal.

How Airasit 50/500 Tablet works:

Airasit 50/500 Tablet combines sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Airasit 50/500 Tablet is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Airasit 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Airasit 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Airasit 50/500 Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Airasit 50/500 Tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should not take Airasit 50/500 Tablets; use is likely to be harmful. Seek medical advice.

What if you forget to take Airasit 50/500 Tablet :

Should you forget a dose of Airasit 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Airasit 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Airasit 50/500 Tablet

Airasit 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Airasit 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Airasit 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Airasit 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Airasit 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Airasit 50/500 Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Airasit 50/500 and seek immediate medical attention.
Airasit 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Airasit 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Airasit 50/500 Tablets are contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Airasit 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Airasit 50/500 Tablet. This rare complication is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol, and should be avoided in such individuals. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged Airasit 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Airasit 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Airasit 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Airasit 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Airasit 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as Metformin-associated lactic acidosis or MALA), is a potential side effect of Airasit 50/500 Tablet. This is due to a buildup of lactic acid in the blood and is rare, but avoided in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Prolonged Airasit 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Airasit 50/500 Tablet
113